Fentanyl Citrate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Fentanyl Citrate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Jan 1, 2012. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-9094-25
Dosage Form
Injection
Presentation
Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)
Initial Posting
Jan 1, 2012

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.